JPN/713
WTO/TBT
JP Japan
  • 30 - Pharmazeutische Erzeugnisse
2021-11-14
2021-10-25

PHARMACEUTICAL PRODUCTS (HS 30)

Partial amendment to the Public Notice on National Release Testing (1 page(s), in English)

Amendment of the provisions for fee and quantity in the "Recombinant Adsorbed Hepatitis B Vaccine (Prepared from Yeast)".

Deletion of the provision for MPL content test in "Recombinant Adsorbed Bivalent Human Papillomavirus-like particle  Vaccine (derived from Trichoplusia ni cells)".

Deletion of a part of the provision for  potency test in "Human prothrombin complex" and "Freeze-dried activated human blood coagulation factor VII concentrate containing factor X." 

Deletion of the provision for rabbit pyrogen test in "Freeze-dried ion-exchange-resin treated human normal immunoglobulin" and "Human anti-thrombin III."